8-KLeadership ChangesCorporate ChangesRegulation FD+1

AGILENT TECHNOLOGIES, INC. 8-K Report, Executive Changes (May 21, 2025)

Filed May 21, 2025For Securities:A

Summary

Agilent Technologies, Inc. announced significant governance changes on May 21, 2025, through an 8-K filing. The Board of Directors has been expanded from 10 to 12 members with the appointment of two new independent directors, Pascal Soriot and Judy Gawlik Brown. Mr. Soriot brings extensive leadership experience from the pharmaceutical industry, most notably as CEO of AstraZeneca, while Ms. Brown offers deep financial and operational expertise from roles at Amgen, Perrigo, and as founder of Downtown Advisory, along with her current independent director experience at Belden Inc. In addition to the board expansion, Agilent's bylaws were amended to lower the supermajority voting threshold for certain corporate actions from 80% to a simple majority. This change aims to streamline decision-making processes. Both new directors have been deemed independent and will receive standard non-employee director compensation. These moves suggest a strategic effort to enhance board oversight and potentially improve corporate agility.

Key Highlights

  • 1Board size increased from 10 to 12 members.
  • 2Pascal Soriot, CEO of AstraZeneca, appointed as a new independent director.
  • 3Judy Gawlik Brown, Founder of Downtown Advisory and former Amgen/Perrigo executive, appointed as a new independent director.
  • 4Both new directors were deemed independent and meet NYSE listing standards.
  • 5Bylaws amended to reduce the supermajority voting requirement for certain actions from 80% to a simple majority.
  • 6New directors will receive standard compensation for non-employee directors.

Frequently Asked Questions

Agilent Technologies appointed Pascal Soriot, currently CEO of AstraZeneca, and Judy Gawlik Brown, Founder of Downtown Advisory and former executive at Amgen and Perrigo, as new independent directors.

The company amended its bylaws to lower the voting threshold for certain actions from an 80% supermajority to a simple majority. This change is intended to facilitate more efficient decision-making and governance.

Yes, both Mr. Soriot and Ms. Brown have been determined by the Board to meet the independence standards adopted by Agilent and comply with New York Stock Exchange corporate governance listing standards.

Mr. Soriot and Ms. Brown will receive the standard compensation paid to Agilent's non-employee directors, pro-rated for the portion of the year they serve. This compensation structure is detailed in the company's proxy statement.